title: A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
authors.affiliation: Critical Path Institute, 1730 E River Rd, Suite 200, Tucson, Arizona, United States.
authors.forename: Marco
authors.initials: M
authors.lastname: Schito
authors.affiliation: FIND, Campus Biotech, Building B2, Level 0, 9, Chemin des Mines, 1202 Geneva, Switzerland.
authors.forename: David L
authors.initials: DL
authors.lastname: Dolinger
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D019295:Computational Biology / Q000379:methods; D003299:Cooperative Behavior; D004359:Drug Therapy, Combination; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics*; D017422:Sequence Analysis, DNA / Q000379:methods; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents
keywords: Database; Drug resistance; Sequencing; Tuberculosis